Accreditation Statistics

As of May 2, 2024

Cellular Therapy Entities

  • Accredited: 262
  • Applicants: 30

Cord Blood Banks

  • Accredited: 48
  • Applicants: 10


Initial Accreditations

  • Abu Dhabi Stem Cell Center, Abu Dhabi, United Arab Emirates | Cellular Therapy Product Processing with Minimal Manipulation
  • CHN - Complexo Hospitalar de Niterói, Rio de Janeiro, Brazil | Adult and Pediatric Allogeneic and Autologous Hematopoietic Progenitor Cell Transplantation, Marrow and  Peripheral Blood Cellular Therapy Product Collection, and Cellular Therapy Product Processing with Minimal Manipulation


A complete list of accredited organizations can be found at

FACT Board of Directors Honors Outgoing and Incoming Members and Officers

Posted in :: 2024 Volume 2 :: Tuesday, April 9th, 2024

During the 2024 Tandem Meetings of ASTCT and CIBMTR, the FACT Board of Directors celebrated the service of several members. These leaders serve FACT, the cellular therapy community, and patients around the world and the Board is deeply appreciative of their commitment to the FACT mission.

Outgoing Member Dr. Elizabeth Shpall Celebrates 25 Years of FACT Servant Leadership!

Elizabeth Shpall, MD, of MD Anderson Cancer Center, began her leadership at FACT as a Founding Board President and her contributions will endure throughout FACT’s future:

Board of Directors
• FACT Founding Board Member and President: 1996-2002
• FACT Past President: 2003-2011
• FACT Board Member and Executive Committee: 2015-2023

• Accreditation Committee – Cord Blood
• Standards Committee – Cord Blood, Common, Immune Effector Cells
• Immune Effector Cell Task Force
• Leadership & Nominations Committee
• Grievance Committee
• New Business Development Task Force

• FACT Inspector for over 20 years performing clinical, apheresis, and cord blood inspections.

In addition to this impressive list of activities, Dr. Shpall’s relationship building, strategic thinking, and medical acumen have truly provided a strong foundation on which FACT can build its future.

Newly Appointed Director Ensures Vital Cord Blood Banking Expertise on Board

As the Director of the Queensland Cord Blood Bank at the Mater and a FACT Inspector for over 10 years, Phillip Johnson, MMedSc(Path), will continue to provide insight into the evolving landscape of cord blood banking and exciting potential of cord-blood-derived stem cells.





Several Board Members Will Continue Serving During this Pivotal Moment of Growth for FACT

After leading FACT through organizational assessments, transition to independent status, and strategic planning, three Board members will provide continuity as we carry out the remainder of FACT’s current strategic plan. Thank you to the following leaders for your dedication!

Abba Zubair, MD, PhD
Mayo Clinic
Navneet Majhail, MD, MS, FASTCT
Sarah Cannon Cancer Institute
Eneida Nemecek, MD
Oregon Health & Science University

New Officers Will Steer the FACT Board of Directors Toward Continued Success

 Two Board members answered the call to serve in executive roles within the Board of Directors:

Vice President
Navneet Majhail, MD, MS, FASTCT
Sarah Cannon Cancer Institute
Nadim Mahmud, MD, PhD
University of Illinois Hospital and Health Sciences System